physicians in New Mexico notified the New Mexico Department of Health and Environment of 3 patients with marked eosinophilia and severe. incapacitating myalgia who had been taking the amino acid L-tryptophan (orally) and whose illness, after thorough clinical evaluation, seemed both unusual and obsc
Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia–Myalgia syndrome
✍ Scribed by Richard M. Silver; Kevin McKinley; Edwin A. Smith; Bonnie Quearry; Yadollah Harati; Esther M. Sternberg; Melvyn P. Heyes
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 732 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objective. To investigate the metabolism of L‐tryptophan (LT) via the kynurenine pathway in patients with the eosinophilia–myalgia syndrome (EMS).
Methods. Measurement of LT, L‐kynurenine, and quinolinic acid in plasma and cerebrospinal fluid (CSF) from subjects with EMS, from asymptomatic users of LT, and from normal subjects.
Results. Plasma LT concentrations were lower in untreated EMS patients (n = 5) than in corticosteroid‐treated EMS patients (n = 5; P < 0.05) and in asymptomatic users of LT (n = 5; P < 0.05). Untreated EMS patients, who had discontinued LT weeks to months prior to study, had significantly higher plasma levels of L‐kynurenine and quinolinic acid than did corticosteroid‐treated EMS patients (P < 0.05), normal subjects (P < 0.02), and asymptomatic users of LT (P < 0.05). EMS patients also had significantly elevated levels of L‐kynurenine (P < 0.05) and quinolinic acid (P < 0.001) in CSF compared with normal subjects. After a 1‐gm oral dose of LT, untreated EMS patients (n = 4) showed lower peak levels of LT and accentuated synthesis of L‐kynurenine and quinolinic acid, compared with these values in corticosteroid‐treated EMS patients (n = 2), who responded like normal subjects (n = 5).
Conclusion. These data demonstrate that during the active phase of EMS, LT metabolism via the kynurenine pathway was accentuated, probably secondary to induction of the enzyme indoleamine‐2,3‐dioxygenase. Ingestion of large amounts of LT (median daily dose 1.5 gm) resulted in high concentrations of kynurenine‐pathway metabolites in blood and extrahepatic tissues, which was accentuated in EMS patients and which may have played a significant role in the pathogenesis of the disease.
📜 SIMILAR VOLUMES
The clinical constellation of leukocytosis, thrombocytosis, and low or absent stainable neutrophil alkaline phosphatase (NAP) is considered characteristic of chronic myelogenous leukemia (CML) [l]. CML with eosinophilic differentiation (eosinophilic leukemia) is well described [2], and leukemia and
## Abstract ## BACKGROUND: Lineage involvement and maturation arrest are considered to have prognostic significance in patients with myelodysplastic syndromes (MDS). However, although the prognostic value of neutropenia, thrombocytopenia, and monocytosis have been documented, little is known about